Retinoblastoma gene in cancer

No Pathway Network information available for Retinoblastoma gene in cancer

Pathways in the Retinoblastoma gene in cancer SuperPath

#	Name	Source	Genes
1	Retinoblastoma gene in cancer	WikiPathways	ABL1 ANLN BARD1 CCDC6 CCNA2 CCNB1 CCNB2 CCND1 CCND3 CCNE1 CCNE2 CDC25A CDC25B CDC45 CDC7 CDK1 CDK2 CDK4 CDK6 CDKN1A CDKN1B CDT1 CHEK1 DCK DHFR DNMT1 E2F1 E2F2 E2F3 FAF1 FANCG H2AZ1 HDAC1 HLTF HMGB1 HMGB2 KIF4A MAPK13 MCM3 MCM4 MCM6 MCM7 MDM2 MIR29B1 MIR29B2 MSH6 MYC NPAT ORC1 PCNA PLK4 POLA1 POLD3 POLE POLE2 PRIM1 PRKDC PRMT2 RABIF RAF1 RB1 RBBP4 RBBP7 RBP1 RFC3 RFC4 RFC5 RPA1 RRM1 RRM2 SAP30 SIN3A SKP2 SMARCA2 SMC1A SMC2 SMC3 STMN1 SUV39H1 TFDP1 TFDP2 TOP2A TP53 TTK TYMS WEE1 (see all 86) (see less)

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	CDC25B	Cell Division Cycle 25B	Protein Coding	1
2	CDK1	Cyclin Dependent Kinase 1	Protein Coding	1
3	CCNE2	Cyclin E2	Protein Coding	1
4	CCNB2	Cyclin B2	Protein Coding	1
5	SMC3	Structural Maintenance Of Chromosomes 3	Protein Coding	1
6	CCNE1	Cyclin E1	Protein Coding	1
7	CCND3	Cyclin D3	Protein Coding	1
8	CCNB1	Cyclin B1	Protein Coding	1
9	CCNA2	Cyclin A2	Protein Coding	1
10	CDC45	Cell Division Cycle 45	Protein Coding	1
11	SMC1A	Structural Maintenance Of Chromosomes 1A	Protein Coding	1
12	CDT1	Chromatin Licensing And DNA Replication Factor 1	Protein Coding	1
13	CCDC6	Coiled-Coil Domain Containing 6	Protein Coding	1
14	WEE1	WEE1 G2 Checkpoint Kinase	Protein Coding	1
15	TYMS	Thymidylate Synthetase	Protein Coding	1
16	TTK	TTK Protein Kinase	Protein Coding	1
17	TP53	Tumor Protein P53	Protein Coding	1
18	TOP2A	DNA Topoisomerase II Alpha	Protein Coding	1
19	TFDP2	Transcription Factor Dp-2	Protein Coding	1
20	TFDP1	Transcription Factor Dp-1	Protein Coding	1
21	SUV39H1	SUV39H1 Histone Lysine Methyltransferase	Protein Coding	1
22	HLTF	Helicase Like Transcription Factor	Protein Coding	1
23	SMARCA2	SWI/SNF Related BAF Chromatin Remodeling Complex Subunit ATPase 2	Protein Coding	1
24	SKP2	S-Phase Kinase Associated Protein 2	Protein Coding	1
25	RRM2	Ribonucleotide Reductase Regulatory Subunit M2	Protein Coding	1
26	RRM1	Ribonucleotide Reductase Catalytic Subunit M1	Protein Coding	1
27	RPA1	Replication Protein A1	Protein Coding	1
28	RFC4	Replication Factor C Subunit 4	Protein Coding	1
29	CCND1	Cyclin D1	Protein Coding	1
30	RBP1	Retinol Binding Protein 1	Protein Coding	1
31	RB1	RB Transcriptional Corepressor 1	Protein Coding	1
32	RAF1	Raf-1 Proto-Oncogene, Serine/Threonine Kinase	Protein Coding	1
33	BARD1	BRCA1 Associated RING Domain 1	Protein Coding	1
34	MAPK13	Mitogen-Activated Protein Kinase 13	Protein Coding	1
35	PRKDC	Protein Kinase, DNA-Activated, Catalytic Subunit	Protein Coding	1
36	ANLN	Anillin, Actin Binding Protein	Protein Coding	1
37	POLE	DNA Polymerase Epsilon, Catalytic Subunit	Protein Coding	1
38	POLA1	DNA Polymerase Alpha 1, Catalytic Subunit	Protein Coding	1
39	PCNA	Proliferating Cell Nuclear Antigen	Protein Coding	1
40	ORC1	Origin Recognition Complex Subunit 1	Protein Coding	1
41	MYC	MYC Proto-Oncogene, BHLH Transcription Factor	Protein Coding	1
42	MDM2	MDM2 Proto-Oncogene	Protein Coding	1
43	MCM6	Minichromosome Maintenance Complex Component 6	Protein Coding	1
44	MCM4	Minichromosome Maintenance Complex Component 4	Protein Coding	1
45	MIR29B2	MicroRNA 29b-2	RNA Gene	1
46	STMN1	Stathmin 1	Protein Coding	1
47	HMGB2	High Mobility Group Box 2	Protein Coding	1
48	HMGB1	High Mobility Group Box 1	Protein Coding	1
49	HDAC1	Histone Deacetylase 1	Protein Coding	1
50	MSH6	MutS Homolog 6	Protein Coding	1
51	SIN3A	SIN3 Transcription Regulator Family Member A	Protein Coding	1
52	ABL1	ABL Proto-Oncogene 1, Non-Receptor Tyrosine Kinase	Protein Coding	1
53	KIF4A	Kinesin Family Member 4A	Protein Coding	1
54	FANCG	FA Complementation Group G	Protein Coding	1
55	E2F3	E2F Transcription Factor 3	Protein Coding	1
56	E2F2	E2F Transcription Factor 2	Protein Coding	1
57	E2F1	E2F Transcription Factor 1	Protein Coding	1
58	DNMT1	DNA Methyltransferase 1	Protein Coding	1
59	DHFR	Dihydrofolate Reductase	Protein Coding	1
60	CHEK1	Checkpoint Kinase 1	Protein Coding	1
61	PLK4	Polo Like Kinase 4	Protein Coding	1
62	POLD3	DNA Polymerase Delta 3, Accessory Subunit	Protein Coding	1
63	SMC2	Structural Maintenance Of Chromosomes 2	Protein Coding	1
64	CDKN1B	Cyclin Dependent Kinase Inhibitor 1B	Protein Coding	1
65	CDKN1A	Cyclin Dependent Kinase Inhibitor 1A	Protein Coding	1
66	CDK6	Cyclin Dependent Kinase 6	Protein Coding	1
67	CDK4	Cyclin Dependent Kinase 4	Protein Coding	1
68	CDK2	Cyclin Dependent Kinase 2	Protein Coding	1
69	DCK	Deoxycytidine Kinase	Protein Coding	1
70	SAP30	Sin3A Associated Protein 30	Protein Coding	1
71	FAF1	Fas Associated Factor 1	Protein Coding	1
72	CDC7	Cell Division Cycle 7	Protein Coding	1
73	RFC5	Replication Factor C Subunit 5	Protein Coding	1
74	RFC3	Replication Factor C Subunit 3	Protein Coding	1
75	RBBP7	RB Binding Protein 7, Chromatin Remodeling Factor	Protein Coding	1
76	RBBP4	RB Binding Protein 4, Chromatin Remodeling Factor	Protein Coding	1
77	RABIF	RAB Interacting Factor	Protein Coding	1
78	PRIM1	DNA Primase Subunit 1	Protein Coding	1
79	POLE2	DNA Polymerase Epsilon 2, Accessory Subunit	Protein Coding	1
80	NPAT	Nuclear Protein, Coactivator Of Histone Transcription	Protein Coding	1
81	MCM7	Minichromosome Maintenance Complex Component 7	Protein Coding	1
82	MCM3	Minichromosome Maintenance Complex Component 3	Protein Coding	1
83	MIR29B1	MicroRNA 29b-1	RNA Gene	1
84	CDC25A	Cell Division Cycle 25A	Protein Coding	1
85	PRMT2	Protein Arginine Methyltransferase 2	Protein Coding	1
86	H2AZ1	H2A.Z Variant Histone 1	Protein Coding	1

Disorders associated with Retinoblastoma gene in cancer SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Meier-gorlin syndrome 1	Enrichment	CDC45, CDT1, MCM7, ORC1	6.51
2	Inherited cancer-predisposing syndrome	Enrichment	BARD1, CDK4, CDKN1B, DHFR, MSH6, POLE, RB1, TP53	5.74
3	Ovarian cancer	Enrichment	BARD1, CDKN1B, FANCG, MSH6, RB1, TP53	4.37
4	Lip and oral cavity carcinoma	Enrichment	ABL1, RB1, TP53	4.28
5	Pituitary stalk interruption syndrome	Enrichment	DNMT1, FANCG, SMARCA2	4.07
6	Osteogenic sarcoma	Enrichment	RB1, TP53	3.93
7	Dedifferentiated liposarcoma	Enrichment	CDK4, MDM2	3.93
8	Squamous cell carcinoma	Enrichment	RB1, TP53	3.93
9	Bone osteosarcoma	Enrichment	RB1, TP53	3.93
10	Well-differentiated liposarcoma	Enrichment	CDK4, MDM2	3.93
11	Gastric cancer	Enrichment	BARD1, CDK4, MSH6, TP53	3.81
12	Small cell cancer of the lung	Enrichment	RB1, TP53	3.63
13	Lynch syndrome 4	Enrichment	MSH6, RB1	3.63
14	Endometrial cancer	Enrichment	BARD1, DHFR, MSH6	3.52
15	Li-fraumeni syndrome	Enrichment	MDM2, TP53	3.23
16	Wiedemann-steiner syndrome	Enrichment	SMC1A, SMC3	3.23
17	Bladder cancer	Enrichment	CDKN1A, RB1, TP53	3.10
18	Multiple endocrine neoplasia, type i	Enrichment	CDKN1A, CDKN1B	3.09
19	B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)	Enrichment	ABL1, TP53	3.09
20	Cornelia de lange syndrome 1	Enrichment	SMC1A, SMC3	2.86
21	Cornelia de lange syndrome	Enrichment	SMC1A, SMC3	2.86
22	Leukemia, chronic lymphocytic	Enrichment	CCND1, TP53	2.76
23	Familial colorectal cancer type x	Enrichment	NPAT, POLE	2.68
24	Colorectal cancer	Enrichment	CCND1, MSH6, POLE, TP53	2.65
25	Hereditary breast carcinoma	Enrichment	BARD1, MSH6, TP53	2.57
26	Lung cancer susceptibility 3	Enrichment	RB1, TP53	2.46
27	Seckel syndrome	Enrichment	PLK4, PRIM1	2.46
28	Rhabdomyosarcoma	Enrichment	MSH6, TP53	2.35
29	Hereditary breast ovarian cancer syndrome	Enrichment	BARD1, MSH6, TP53	2.29
30	Myeloma, multiple	Enrichment	BARD1, CCND1, TP53	2.27
31	Cystic fibrosis with helicobacter pylori gastritis, megaloblastic anemia, and impaired intellectual development	Enrichment	POLE	2.20
32	Developmental and epileptic encephalopathy 85 with or without midline brain defects	Enrichment	SMC1A	2.20
33	Van esch-o'driscoll syndrome	Enrichment	POLA1	2.20
34	Spermatogenic failure, x-linked, 9	Enrichment	RBBP7	2.20
35	Intellectual developmental disorder, x-linked 100	Enrichment	KIF4A	2.20
36	Taurodontism, microdontia, and dens invaginatus	Enrichment	KIF4A	2.20
37	Cornelia de lange syndrome 3 with or without midline brain defects	Enrichment	SMC3	2.20
38	Noonan syndrome 5	Enrichment	RAF1	2.20
39	Melanoma, cutaneous malignant 3	Enrichment	CDK4	2.20
40	Brachyphalangy, polydactyly, and tibial aplasia/hypoplasia	Enrichment	HMGB1	2.20
41	Cardiomyopathy, dilated, 1nn	Enrichment	RAF1	2.20
42	Lactose intolerance, adult type	Enrichment	MCM6	2.20
43	Microcephaly 12, primary, autosomal recessive	Enrichment	CDK6	2.20
44	Microcephaly and chorioretinopathy, autosomal recessive, 2	Enrichment	PLK4	2.20
45	Focal segmental glomerulosclerosis 8	Enrichment	ANLN	2.20
46	Accelerated tumor formation	Enrichment	MDM2	2.20
47	Fanconi anemia, complementation group g	Enrichment	FANCG	2.20
48	Colorectal cancer 12	Enrichment	POLE	2.20
49	Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 6	Enrichment	RPA1	2.20
50	Pigmentary disorder, reticulate, with systemic manifestations, x-linked	Enrichment	POLA1	2.20
51	Lessel-kubisch syndrome	Enrichment	MDM2	2.20
52	Bone marrow failure syndrome 5	Enrichment	TP53	2.20
53	Meier-gorlin syndrome 4	Enrichment	CDT1	2.20
54	Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 6	Enrichment	RRM1	2.20
55	Papilloma of choroid plexus	Enrichment	TP53	2.20
56	Anisometropia	Enrichment	MCM7	2.20
57	Basal cell carcinoma 7	Enrichment	TP53	2.20
58	Anaplastic thyroid carcinoma	Enrichment	TP53	2.20
59	Immunodeficiency 54	Enrichment	MCM4	2.20
60	Neuroendocrine tumor	Enrichment	CDKN1B	2.20
61	Leopard syndrome 2	Enrichment	RAF1	2.20
62	Immunodeficiency 26 with or without neurologic abnormalities	Enrichment	PRKDC	2.20
63	Ataxia-telangiectasia-like disorder 2	Enrichment	PCNA	2.20
64	Microcephaly and chorioretinopathy 2	Enrichment	PLK4	2.20
65	Megaloblastic anemia due to dihydrofolate reductase deficiency	Enrichment	DHFR	2.20
66	Ductal carcinoma in situ	Enrichment	TP53	2.20
67	Meier-gorlin syndrome 7	Enrichment	CDC45	2.20
68	Blepharophimosis-impaired intellectual development syndrome	Enrichment	SMARCA2	2.20
69	Trigonitis	Enrichment	RAF1	2.20
70	Thyroid gland undifferentiated carcinoma	Enrichment	TP53	2.20
71	Trilateral retinoblastoma	Enrichment	RB1	2.20
72	Small-cell carcinoma of the ovary of hypercalcemic type	Enrichment	TP53	2.20
73	Diffuse pediatric-type high-grade glioma, h3-wildtype and idh-wildtype	Enrichment	TP53	2.20
74	Morimoto-ryu-malicdan neuromuscular syndrome	Enrichment	RFC4	2.20
75	Chromosome 15q24 deletion syndrome	Enrichment	SIN3A	2.20
76	Oocyte/zygote/embryo maturation arrest 21	Enrichment	CHEK1	2.20
77	Immunodeficiency 122	Enrichment	POLD3	2.20
78	Choroid plexus cancer	Enrichment	TP53	2.20
79	Pleomorphic xanthoastrocytoma	Enrichment	TP53	2.20
80	Lung oat cell carcinoma	Enrichment	RB1	2.20
81	Hepatoblastoma	Enrichment	BARD1, TP53	2.11
82	Precursor t-cell acute lymphoblastic leukemia	Enrichment	ABL1, MYC	2.04
83	Pancreatic cancer	Enrichment	FANCG, TP53	1.96
84	Breast cancer	Enrichment	BARD1, MSH6, TP53	1.92
85	Burkitt lymphoma	Enrichment	MYC	1.90
86	Adrenocortical carcinoma, hereditary	Enrichment	TP53	1.90
87	Cervical cancer	Enrichment	TP53	1.90
88	Cornelia de lange syndrome 2	Enrichment	SMC1A	1.90
89	Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies	Enrichment	POLE	1.90
90	Chromosome 13q14 deletion syndrome	Enrichment	RB1	1.90
91	Lymphoma, hodgkin, classic	Enrichment	TP53	1.90
92	Multiple endocrine neoplasia, type iv	Enrichment	CDKN1B	1.90
93	Congenital heart defects and skeletal malformations syndrome	Enrichment	ABL1	1.90
94	Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency	Enrichment	POLE	1.90
95	Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	Enrichment	DNMT1	1.90
96	Primordial dwarfism-immunodeficiency-lipodystrophy syndrome	Enrichment	PRIM1	1.90
97	Congenital fibrosarcoma	Enrichment	TP53	1.90
98	Li-fraumeni syndrome 1	Enrichment	TP53	1.90
99	Sarcoma	Enrichment	TP53	1.90
100	Witteveen-kolk syndrome	Enrichment	SIN3A	1.90
101	Facial dysmorphism, immunodeficiency, livedo, and short stature	Enrichment	POLE	1.90
102	Cervix carcinoma	Enrichment	TP53	1.90
103	Hodgkin's lymphoma	Enrichment	TP53	1.90
104	Blepharophimosis - intellectual disability syndrome	Enrichment	SMARCA2	1.90
105	Dyskeratosis congenita, digenic	Enrichment	TYMS	1.90
106	Mismatch repair cancer syndrome 3	Enrichment	MSH6	1.90
107	Familial retinoblastoma	Enrichment	RB1	1.90
108	Pleomorphic rhabdomyosarcoma	Enrichment	TP53	1.90
109	Prostate cancer	Enrichment	MSH6, TP53	1.84
110	Primary autosomal recessive microcephaly	Enrichment	CDK6, MCM7	1.76
111	Retinoblastoma	Enrichment	RB1	1.72
112	Partington syndrome	Enrichment	POLA1	1.72
113	Nasopharyngeal carcinoma	Enrichment	TP53	1.72
114	Woolly hair, autosomal recessive 3	Enrichment	RB1	1.72
115	Neuropathy, hereditary sensory, type ie	Enrichment	DNMT1	1.72
116	Lynch syndrome 5	Enrichment	MSH6	1.72
117	Familial adenomatous polyposis 4	Enrichment	DHFR	1.72
118	Hypotrichosis 8	Enrichment	RB1	1.72
119	High-grade b-cell lymphoma double-hit/triple-hit	Enrichment	MYC	1.72
120	Atypical teratoid rhabdoid tumor	Enrichment	TP53	1.72
121	Anaplastic astrocytoma	Enrichment	TP53	1.72
122	T-cell acute lymphoblastic leukemia	Enrichment	ABL1	1.72
123	Adenocarcinoma	Enrichment	TP53	1.72
124	Childhood apraxia of speech	Enrichment	RFC3	1.72
125	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities	Enrichment	MSH6	1.72
126	Colon adenocarcinoma	Enrichment	MSH6	1.72
127	Polymerase proofreading-related polyposis	Enrichment	POLE	1.72
128	Gaucher disease, type i	Enrichment	MSH6	1.60
129	Thyroid cancer, nonmedullary, 1	Enrichment	TP53	1.60
130	Mismatch repair cancer syndrome 1	Enrichment	MSH6	1.60
131	Astigmatism	Enrichment	MCM7	1.60
132	Nicolaides-baraitser syndrome	Enrichment	SMARCA2	1.60
133	Mantle cell lymphoma	Enrichment	CCND1	1.60
134	Blepharophimosis	Enrichment	SMARCA2	1.60
135	Enophthalmos	Enrichment	MCM7	1.60
136	Lung sarcomatoid carcinoma	Enrichment	TP53	1.60
137	Chronic myelogenous leukemia, bcr-abl1 positive	Enrichment	ABL1	1.60
138	Embryonal rhabdomyosarcoma	Enrichment	TP53	1.60
139	Noonan syndrome with multiple lentigines	Enrichment	RAF1	1.60
140	Smarca2-related nicolaides-baraitser syndrome	Enrichment	SMARCA2	1.60
141	Autosomal recessive chorioretinopathy-microcephaly syndrome	Enrichment	PLK4	1.60
142	Primary hyperparathyroidism	Enrichment	CDKN1B	1.60
143	Male infertility due to gonadal dysgenesis or sperm disorder	Enrichment	CHEK1	1.60
144	Von hippel-lindau syndrome	Enrichment	CCND1	1.50
145	Rhabdomyosarcoma 2	Enrichment	TP53	1.50
146	Lymphoma	Enrichment	TP53	1.50
147	Acute megakaryocytic leukemia	Enrichment	TP53	1.50
148	Farsightedness	Enrichment	MCM7	1.50
149	Adrenocortical carcinoma	Enrichment	TP53	1.43
150	Breast adenocarcinoma	Enrichment	TP53	1.43
151	Multicystic kidney dysplasia	Enrichment	KIF4A	1.43
152	Multicystic dysplastic kidney	Enrichment	KIF4A	1.43
153	Microcephaly	Enrichment	ABL1, MCM7, SMC1A	1.36
154	Esophageal cancer	Enrichment	TP53	1.36
155	Squamous cell carcinoma, head and neck	Enrichment	TP53	1.36
156	Leukemia, chronic myeloid	Enrichment	ABL1	1.36
157	Noonan syndrome 3	Enrichment	RAF1	1.36
158	Hereditary sensory and autonomic neuropathy type 1	Enrichment	DNMT1	1.36
159	Essential thrombocythemia	Enrichment	TP53	1.36
160	Gallbladder cancer	Enrichment	TP53	1.36
161	Pilomyxoid astrocytoma	Enrichment	RAF1	1.36
162	Moyamoya angiopathy	Enrichment	ABL1	1.36
163	Melanocytic nevus syndrome, congenital	Enrichment	RAF1	1.30
164	Glioma susceptibility 1	Enrichment	TP53	1.30
165	Lymphoma, non-hodgkin, familial	Enrichment	TP53	1.30
166	Rett syndrome, congenital variant	Enrichment	SMC1A	1.30
167	Adult hepatocellular carcinoma	Enrichment	TP53	1.25
168	Primary hyperaldosteronism	Enrichment	TP53	1.25
169	Lynch syndrome 1	Enrichment	MSH6	1.21
170	Familial colorectal cancer	Enrichment	TP53	1.21
171	Myelodysplastic syndrome	Enrichment	TP53	1.17
172	Uterine corpus cancer	Enrichment	MSH6	1.17
173	Heart disease	Enrichment	ABL1	1.07
174	Hydrocephalus	Enrichment	KIF4A	1.04
175	Lynch syndrome	Enrichment	MSH6	1.04
176	Noonan syndrome and noonan-related syndrome	Enrichment	RAF1	1.04
177	Hydrocephalus, congenital, 1	Enrichment	KIF4A	1.01
178	Gliosarcoma	Enrichment	TP53	1.01
179	Melanoma, cutaneous malignant 1	Enrichment	CDK4	0.99
180	Polycystic liver disease	Enrichment	CDC25A	0.99
181	Giant cell glioblastoma	Enrichment	TP53	0.99
182	Autosomal dominant polycystic liver disease	Enrichment	CDC25A	0.99
183	Semilobar holoprosencephaly	Enrichment	SMC1A	0.97
184	Diffuse large b-cell lymphoma	Enrichment	TP53	0.94
185	Dyskeratosis congenita	Enrichment	TYMS	0.94
186	Hepatocellular carcinoma	Enrichment	TP53	0.88
187	Microphthalmia	Enrichment	MCM7	0.88
188	Diamond-blackfan anemia 1	Enrichment	TP53	0.87
189	Noonan syndrome 1	Enrichment	RAF1	0.87
190	Cardiomyopathy, familial hypertrophic, 1	Enrichment	RAF1	0.85
191	Rasopathy	Enrichment	RAF1	0.82
192	Differentiated thyroid carcinoma	Enrichment	CCDC6	0.77
193	Familial hypertrophic cardiomyopathy	Enrichment	RAF1	0.72
194	Genetic steroid-resistant nephrotic syndrome	Enrichment	ANLN	0.71
195	Fanconi anemia, complementation group a	Enrichment	FANCG	0.70
196	Left ventricular noncompaction	Enrichment	RAF1	0.70
197	Diamond-blackfan anemia	Enrichment	TP53	0.69
198	Leukemia, acute myeloid	Enrichment	TP53	0.65
199	Spastic ataxia	Enrichment	DNMT1	0.54
200	Familial isolated dilated cardiomyopathy	Enrichment	RAF1	0.54
201	Dilated cardiomyopathy	Enrichment	RAF1	0.40
202	Congenital nervous system abnormality	Enrichment	SMC1A	0.31
203	Nervous system disease	Enrichment	SMC1A	0.31
204	Autism spectrum disorder	Enrichment	SMC3	0.30

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

Retinoblastoma gene in cancer

Pathway Network for Retinoblastoma gene in cancer

Member Pathways for Retinoblastoma gene in cancer

Pathways in the Retinoblastoma gene in cancer SuperPath

Associated Genes for Retinoblastoma gene in cancer

Associated Disorders for Retinoblastoma gene in cancer

Disorders associated with Retinoblastoma gene in cancer SuperPath

STRING Interaction Network for Retinoblastoma gene in cancer

Sources for Retinoblastoma gene in cancer